T N Witte1, A L Ginsberg. 1. Department of Internal Medicine, The George Washington University, Washington, DC 20037, USA.
Abstract
BACKGROUND: At least one-third of patients with inflammatory bowel disease do not respond or are intolerant to therapy with 6-mercaptopurine (6-MP). A subgroup fails to attain optimal levels of 6-thioguanine nucleotide (6-TGN) and instead shunts to 6-methylmercaptopurine nucleotide (6-MMPN). PATIENTS AND METHODS: A retrospective chart review was conducted, and four patients are described who had been previously unable to achieve optimal 6-TGN metabolite levels until allopurinol was added to their treatment. RESULTS: All four patients achieved optimal 6-TGN levels and undetectable 6-MMPN with a mean 6-MP dose of 0.49 mg/kg. Three achieved steroid-free clinical remission. Two of those three patients had normalization of liver enzymes; one patient had baseline normal liver enzymes despite an initial 6-MMPN level of 27,369 pmol/8 x 10(8) red blood cells. Two patients experienced reversible leukopenia. CONCLUSIONS: Combination allopurinol and low-dose 6-MP is an effective means to achieve optimal metabolite levels and steroid-free clinical remission in previously refractory patients. Caution is advised.
BACKGROUND: At least one-third of patients with inflammatory bowel disease do not respond or are intolerant to therapy with 6-mercaptopurine (6-MP). A subgroup fails to attain optimal levels of 6-thioguanine nucleotide (6-TGN) and instead shunts to 6-methylmercaptopurine nucleotide (6-MMPN). PATIENTS AND METHODS: A retrospective chart review was conducted, and four patients are described who had been previously unable to achieve optimal 6-TGN metabolite levels until allopurinol was added to their treatment. RESULTS: All four patients achieved optimal 6-TGN levels and undetectable 6-MMPN with a mean 6-MP dose of 0.49 mg/kg. Three achieved steroid-free clinical remission. Two of those three patients had normalization of liver enzymes; one patient had baseline normal liver enzymes despite an initial 6-MMPN level of 27,369 pmol/8 x 10(8) red blood cells. Two patients experienced reversible leukopenia. CONCLUSIONS: Combination allopurinol and low-dose 6-MP is an effective means to achieve optimal metabolite levels and steroid-free clinical remission in previously refractory patients. Caution is advised.
Authors: M P Sparrow; S A Hande; S Friedman; W C Lim; S I Reddy; D Cao; S B Hanauer Journal: Aliment Pharmacol Ther Date: 2005-09-01 Impact factor: 8.171
Authors: W J Sandborn; W J Tremaine; D C Wolf; S R Targan; C A Sninsky; L R Sutherland; S B Hanauer; J W McDonald; B G Feagan; R N Fedorak; K L Isaacs; M G Pike; D C Mays; J J Lipsky; S Gordon; C S Kleoudis; R H Murdock Journal: Gastroenterology Date: 1999-09 Impact factor: 22.682
Authors: Fady Daniel; Jean-François Cadranel; Philippe Seksik; Alain Cazier; Jean-Paul Duong Van Huyen; Marianne Ziol; Pierre Coutarel; Patrick Loison; Raymond Jian; Philippe Marteau Journal: Gastroenterol Clin Biol Date: 2005-05